GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (XCNQ:DOSE) » Definitions » Dividend Payout Ratio

Rapid Dose Therapeutics (XCNQ:DOSE) Dividend Payout Ratio : 0.00 (As of Nov. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Rapid Dose Therapeutics Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Rapid Dose Therapeutics's Dividend Payout Ratio for the months ended in Nov. 2024 was 0.00.

The historical rank and industry rank for Rapid Dose Therapeutics's Dividend Payout Ratio or its related term are showing as below:


XCNQ:DOSE's Dividend Payout Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 0.45
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2025-03-28), the Dividend Yield % of Rapid Dose Therapeutics is 0.00%.

Rapid Dose Therapeutics's Dividends per Share for the months ended in Nov. 2024 was C$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Rapid Dose Therapeutics Dividend Payout Ratio Historical Data

The historical data trend for Rapid Dose Therapeutics's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Dose Therapeutics Dividend Payout Ratio Chart

Rapid Dose Therapeutics Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Rapid Dose Therapeutics Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Rapid Dose Therapeutics's Dividend Payout Ratio

For the Biotechnology subindustry, Rapid Dose Therapeutics's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rapid Dose Therapeutics's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rapid Dose Therapeutics's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Rapid Dose Therapeutics's Dividend Payout Ratio falls into.


;
;

Rapid Dose Therapeutics Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Rapid Dose Therapeutics's Dividend Payout Ratio for the fiscal year that ended in Feb. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Feb. 2024 )/ EPS without NRI (A: Feb. 2024 )
=0/ -0.035
=N/A

Rapid Dose Therapeutics's Dividend Payout Ratio for the quarter that ended in Nov. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Nov. 2024 )/ EPS without NRI (Q: Nov. 2024 )
=0/ -0.01
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rapid Dose Therapeutics (XCNQ:DOSE) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Rapid Dose Therapeutics Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Rapid Dose Therapeutics's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Rapid Dose Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (XCNQ:DOSE) » Definitions » Dividend Payout Ratio
Comparable Companies
TSXV:HEM TSX:BCT XCNQ:MDMA NEOE:BMND XCNQ:PHRM XCNQ:TELI TSXV:GSD TSXV:TTI TSXV:SBM XCNQ:PREV VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
1121 Walkers Line, Unit 3, Burlington, ON, CAN, L7N 2G4
Website
https://www.rapid-dose.com
Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.
Executives
Mark Upsdell Director
Brian Howlett Director

Rapid Dose Therapeutics Headlines

No Headlines